Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,574 total articles
Copart (CPRT) is an operationally healthy online vehicle auction platform with high returns on capital, robust free cash flow and a valuation that looks reasonable for a mature market leader. Recent earnings hiccups and near-term growth slowdown have pushed the stock below key moving averages; that creates a tradeable entry for investors seeking ex…
Sanmina's $3B purchase of ZT Systems' U.S. data center manufacturing assets and the preferred-partner tie to AMD create a near-term revenue inflection and longer-term margin upside. Valuation is expensive on P/E but reasonable on FCF yield; we upgrade to a buy and propose a trade with a $290 target and $220 stop over a 180 trading-day horizon.
Nanobiotix is a late-clinical stage French biotech developing NanoXray radioenhancers (NBTXR3 / JNJ-1900) and a separate Nanoprimer platform. Recent Phase 2 lung data and a €85m/ ~$100m follow-on that closed in May 2026 give the company runway into 2029. At a $1.72B market cap and current ADS price near $34.04, the stock offers asymmetric upside if…
Armanino Foods (AMNF) is a small-cap specialty foods producer trading at $10.18 with a market cap of $326M. If management follows through on capacity expansion via a new manufacturing facility, the company can convert underutilized fixed costs into higher revenue and cleaner earnings growth. This trade idea targets a move toward $12.50 over a mid-t…
Take-Two (TTWO) is a tradeable long ahead of Grand Theft Auto VI's big launch cycle. The preorder announcement and improving cash flow profile give a clear catalyst; however, high multiples and macro-driven console price pressure justify a defined stop and tempered position sizing.
TIC Solutions' market value sits well below last year's highs, book-value looks reasonable and short positioning is elevated. For traders who want exposure to a beaten-down inspection-and-testing name, a tactical long with a clear stop and a mid-term target offers asymmetric reward-to-risk.
Intel is trading like a very different company than the one that hit a 52-week low in 2025. With a $660+ billion market cap, rapid multiple expansion, and several tangible catalysts - including a U.S. manufacturing push and renewed foundry momentum - I think the market will continue to tolerate a premium valuation. This is a trade, not a long-term …
Airbus just scored a headline-grabbing A220 order that masks a tougher near-term execution picture. The order story is real, but production cadence, margin compression on narrowbodies and military/defense timing create a window for a tactical short. Trade plan included for a mid-term (45 trading days) horizon.
Starbucks is showing signs of a durable turnaround: accelerating comps and margin leverage have driven earnings growth and cash flow stability. Valuation is not cheap, but improving fundamentals and a ~2.4% yield make a mid-term long trade attractive. Entry $103.53, stop $95.00, target $125.00 for a 45-trading-day trade plan.
Viridian has been punished for mixed Phase 3 readouts, but the market may be over-discounting the company's IGF-1R franchise and downstream FcRn assets. With an upcoming FDA decision for veligrotug on 06/30/2026 and a capital base that supports near-term execution, VRDN offers asymmetric upside versus clearly definable downside.
Workday (WDAY) trades at roughly $29B market cap, ~3.0x trailing sales and sub-10x free cash flow despite slowing top-line comps. Agentic AI adoption is scaling quickly (AI offerings up ~200% YoY, approaching $500M ARR). This trade idea buys the dislocation: a long-term (180 trading days) tactical position at $116 with a $105 stop and $180 target, …
Vista Gold (VGZ) trades like a beaten exploration name yet holds a near-feasibility gold project, a clean balance sheet and an EV of roughly $250M. This trade plan buys the optionality on Mt Todd with tight risk control: entry $1.92, stop $1.50, primary target $2.50 (mid-term). The idea is a tactical long sized to withstand binary project and gold-…
Hydreight's VSDHOne appears to be moving from pilot phase into commercial sales. Limited top-line disclosure has frustrated investors, but recent channel reports and anecdotal hospital adoption suggest a meaningful inflection. This is a tactical long: enter at $1.20, stop $0.90, target $2.40. Trade horizon: mid term (45 trading days).
TKO Group combines two of the most durable live-entertainment franchises (UFC and WWE) with a growing licensing and media-rights machine. Strong free cash flow, shareholder-friendly actions (buybacks, dividend hike, insider purchases) and improving event demand create a set-up for a tactical swing long. Valuation is not dirt-cheap, so position sizi…
Rocket Lab's sell-off since the SpaceX IPO has created a tradeable entry into a company that pairs rapid launch capability with spacecraft engineering and government contracts. The stock is rich by traditional multiples but operational strengths - demonstrated responsive launches and expanding space-systems revenue - give a path to justify a higher…
Adobe shares have been punished on macro and strategy fears, but the underlying cash flows, profitability and balance sheet leave room for a disciplined long trade. Entry at current levels, stop below recent low and a sensible target capture a favorable risk/reward while management executes AI product rollouts.
Avino Silver & Gold Mines (ASM) trades at $5.65 with a market cap just under $1.0B. The case: a durable silver market, shareholder-friendly actions in the past, and visible upside if management can scale output meaningfully. This is a long trade that assumes the market re-rates on production expansion; set an entry at $5.50, a stop at $4.00 and an …
HydroGraph Clean Pwr (HGRAF) is a speculative long trade that targets a volatile rebound driven by technical oversold conditions and concentrated short positioning. Entry at $3.85, stop at $2.50 and a $7.50 target reflect asymmetric upside versus defined downside. This is a high-risk, event-driven bet best sized small and watched closely for diluti…
Fair Isaac (FICO) has re-emerged as a compelling long after a recent pullback. Strong earnings, near-$1B free cash flow and a P/E in the mid-30s create a valuation that is attractive given the company’s high returns on assets and recurring revenue mix. This trade proposes a long entry at $1,140 with a $1,500 target over 180 trading days and a $980 …
Nvidia's leadership in AI inference and record data-center revenue give the company strong secular tailwinds. If improving China access materializes, it would add incremental growth without meaningfully changing the already-robust cash-flow profile. Trade plan: buy on or near $200.66, stop at $170.00, target $300.00 over a 180-trading-day horizon.
ServiceNow is a high-quality enterprise SaaS business that has pulled back from its 52-week high and now trades at attractive entry levels for investors willing to tolerate near-term macro and sentiment noise. The company's Now Platform, growing AI commitments and strong free cash flow offer a catalyst-rich path to a return to double-digit revenue …
Abercrombie & Fitch is trading at a single-digit P/E and attractive EV multiples while reporting steady top-line growth and strong free cash flow. Recent beats, a Hollister collaboration with Target and explicit buyback plans provide near-term catalysts. This trade idea outlines an actionable long with entry, stop and target for a 180-trading-day h…
Danaos (DAC) offers a rare combination for the shipping space: sizeable contracted revenue backlog, strong reported liquidity, and a bargain-bin valuation. The stock trades at a low PE (4.5) and PB (0.59) against a $4.3B contracted backlog and $1.4B of liquidity. We lay out a mid-term trade to capture re-rating and execution on new charters while e…
British American Tobacco (BTI) offers a 5%+ yield, reasonable valuation (P/E ~13), and diversified product exposure (oral pouches, smoke-free initiatives, selective cannabis investments). For investors looking to step away from AI-driven volatility, BTI is a pragmatic long trade: buy for income and a steady upside to $68 over the next 180 trading d…
Design Therapeutics reported dose-dependent clinical improvements and robust biomarker lifts from four-week IV data in RESTORE-FA (DT-216P2). With management signaling movement toward registrational development and multiple programs advancing, DSGN ($13.81) offers an asymmetric risk/reward for a long-term trade. This plan targets upside toward $18 …
